WallStreetZenWallStreetZen

NYSEMKT: CMT
Core Molding Technologies Inc Stock

$19.57+0.23 (+1.19%)
Updated Apr 23, 2024
CMT Price
$19.57
Fair Value Price
N/A
Market Cap
$176.93M
52 Week Low
$16.00
52 Week High
$30.09
P/E
8.26x
P/B
1.27x
P/S
0.47x
PEG
0.1x
Dividend Yield
N/A
Revenue
$357.74M
Earnings
$20.32M
Gross Margin
18%
Operating Margin
7.48%
Profit Margin
5.7%
Debt to Equity
0.54
Operating Cash Flow
$35M
Beta
0.66
Next Earnings
May 7, 2024
Ex-Dividend
N/A
Next Dividend
N/A

CMT Overview

Core Molding Technologies, Inc. engages in the manufacture of sheet molding compound; and molding of fiberglass reinforced plastics. The company is headquartered in Columbus, Ohio and currently employs 2,190 full-time employees. The firm along with its subsidiaries operates in the plastics market in a family of products known as reinforced plastics. The company operates through manufacturing of SMC and molder of fiberglass reinforced plastics segment. The company produces and sells SMC and molded products for varied markets, such as medium and heavy-duty trucks, automobiles, marine, construction and other commercial markets. The company specializes in large-format moldings and offers a range of fiberglass processes, including compression molding of SMC, glass mat thermoplastics, bulk molding compounds and direct long-fiber thermoplastics, spray-up, hand-lay-up, and resin transfer molding. The company offers reaction injection molding, utilizing dicyclopentadiene technology. The company operates over five production facilities in Columbus, Ohio; Batavia, Ohio; Gaffney, South Carolina; Winona, Minnesota, and Matamoros, Mexico.

Zen Score

–
Industry Average (36)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CMT scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CMT ($19.57) is trading below its intrinsic value of $80.95, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CMT is good value based on its earnings relative to its share price (8.26x), compared to the US market average (41.92x)
P/E vs Market Valuation
CMT is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more CMT due diligence checks available for Premium users.

Be the first to know about important CMT news, forecast changes, insider trades & much more!

Valuation

CMT price to earnings (PE)

For valuing profitable companies with steady earnings
Company
8.26x
Industry
30.21x
Market
41.92x
CMT is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CMT is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

CMT price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.27x
Industry
3.36x
CMT is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CMT price to earnings growth (PEG)

For valuing profitable companies with growth potential
CMT is good value based... subscribe to Premium to read more.
PEG Value Valuation

CMT's financial health

Profit margin

Revenue
$73.8M
Net Income
$2.2M
Profit Margin
3%
CMT's Earnings (EBIT) of $26.76M... subscribe to Premium to read more.
Interest Coverage Financials
CMT's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$213.4M
Liabilities
$74.4M
Debt to equity
0.54
CMT's short-term assets ($102.88M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CMT's short-term assets ($102.88M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CMT's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CMT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$8.7M
Investing
-$2.3M
Financing
-$327.0k
CMT's operating cash flow ($34.84M)... subscribe to Premium to read more.
Debt Coverage Financials

CMT vs Specialty Chemical Stocks

TickerMarket Cap1d %P/EP/B
CMT$176.93M+1.19%8.26x1.27x
GEVO$170.75M+1.28%-2.54x0.31x
NTIC$153.01M+3.97%33.81x2.24x
ALTO$144.58M+0.53%-4.78x0.52x
LOOP$130.70M+2.61%-11.96x6.91x

Core Molding Technologies Stock FAQ

What is Core Molding Technologies's quote symbol?

(NYSEMKT: CMT) Core Molding Technologies trades on the NYSEMKT under the ticker symbol CMT. Core Molding Technologies stock quotes can also be displayed as NYSEMKT: CMT.

If you're new to stock investing, here's how to buy Core Molding Technologies stock.

What is the 52 week high and low for Core Molding Technologies (NYSEMKT: CMT)?

(NYSEMKT: CMT) Core Molding Technologies's 52-week high was $30.09, and its 52-week low was $16.00. It is currently -34.96% from its 52-week high and 22.31% from its 52-week low.

How much is Core Molding Technologies stock worth today?

(NYSEMKT: CMT) Core Molding Technologies currently has 9,040,704 outstanding shares. With Core Molding Technologies stock trading at $19.57 per share, the total value of Core Molding Technologies stock (market capitalization) is $176.93M.

Core Molding Technologies stock was originally listed at a price of $3.69 in Dec 31, 1997. If you had invested in Core Molding Technologies stock at $3.69, your return over the last 26 years would have been 430.35%, for an annualized return of 6.63% (not including any dividends or dividend reinvestments).

How much is Core Molding Technologies's stock price per share?

(NYSEMKT: CMT) Core Molding Technologies stock price per share is $19.57 today (as of Apr 23, 2024).

What is Core Molding Technologies's Market Cap?

(NYSEMKT: CMT) Core Molding Technologies's market cap is $176.93M, as of Apr 24, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Core Molding Technologies's market cap is calculated by multiplying CMT's current stock price of $19.57 by CMT's total outstanding shares of 9,040,704.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.